ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Measles Vaccine Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-34D11827
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Measles Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Measles Vaccine Market Research Report 2025

Code: QYRE-Auto-34D11827
Report
August 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Sanofi Pasteur
Merck
Novartis
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
MedImmune
Johnson & Johnson
CSL Limited
Serum Institute of India
Pfizer Inc
Johnson & Johnson

Measles Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Measles Vaccine Market

Measles Vaccine Market

The global market for Measles Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Measles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles Vaccine.
The Measles Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Measles Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Measles Vaccine Market Report

Report Metric Details
Report Name Measles Vaccine Market
CAGR 5%
Segment by Type
Segment by Application
  • Children
  • Adults
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, CSL Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Measles Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Measles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Measles Vaccine Market report?

Ans: The main players in the Measles Vaccine Market are GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic, Emergent Biosolutions, Medimmune, Johnson & Johnson, CSL Limited

What are the Application segmentation covered in the Measles Vaccine Market report?

Ans: The Applications covered in the Measles Vaccine Market report are Children, Adults

What are the Type segmentation covered in the Measles Vaccine Market report?

Ans: The Types covered in the Measles Vaccine Market report are Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Recommended Reports

Human Vaccines

Flu & Combination Vaccines

Innovative Vaccine Technologies

1 Measles Vaccine Market Overview
1.1 Product Definition
1.2 Measles Vaccine by Type
1.2.1 Global Measles Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Measles Vaccine by Application
1.3.1 Global Measles Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Children
1.3.3 Adults
1.4 Global Measles Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles Vaccine Revenue 2020-2031
1.4.2 Global Measles Vaccine Sales 2020-2031
1.4.3 Global Measles Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Measles Vaccine Market Competition by Manufacturers
2.1 Global Measles Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Measles Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Measles Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Measles Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measles Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Measles Vaccine, Date of Enter into This Industry
2.8 Global Measles Vaccine Market Competitive Situation and Trends
2.8.1 Global Measles Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Measles Vaccine Players Market Share by Revenue
2.8.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Measles Vaccine Market Scenario by Region
3.1 Global Measles Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Measles Vaccine Sales by Region: 2020-2031
3.2.1 Global Measles Vaccine Sales by Region: 2020-2025
3.2.2 Global Measles Vaccine Sales by Region: 2026-2031
3.3 Global Measles Vaccine Revenue by Region: 2020-2031
3.3.1 Global Measles Vaccine Revenue by Region: 2020-2025
3.3.2 Global Measles Vaccine Revenue by Region: 2026-2031
3.4 North America Measles Vaccine Market Facts & Figures by Country
3.4.1 North America Measles Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Measles Vaccine Sales by Country (2020-2031)
3.4.3 North America Measles Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Measles Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Measles Vaccine Sales by Country (2020-2031)
3.5.3 Europe Measles Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Measles Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Measles Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Measles Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Measles Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Measles Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Measles Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Measles Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Measles Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles Vaccine Sales by Type (2020-2031)
4.1.1 Global Measles Vaccine Sales by Type (2020-2025)
4.1.2 Global Measles Vaccine Sales by Type (2026-2031)
4.1.3 Global Measles Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Measles Vaccine Revenue by Type (2020-2031)
4.2.1 Global Measles Vaccine Revenue by Type (2020-2025)
4.2.2 Global Measles Vaccine Revenue by Type (2026-2031)
4.2.3 Global Measles Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Measles Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Measles Vaccine Sales by Application (2020-2031)
5.1.1 Global Measles Vaccine Sales by Application (2020-2025)
5.1.2 Global Measles Vaccine Sales by Application (2026-2031)
5.1.3 Global Measles Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Measles Vaccine Revenue by Application (2020-2031)
5.2.1 Global Measles Vaccine Revenue by Application (2020-2025)
5.2.2 Global Measles Vaccine Revenue by Application (2026-2031)
5.2.3 Global Measles Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Measles Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Measles Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Company Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi-Pasteur Measles Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Measles Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Measles Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Measles Vaccine Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Company Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Serum Institute of India Measles Vaccine Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 China National Biotech Group
6.7.1 China National Biotech Group Company Information
6.7.2 China National Biotech Group Description and Business Overview
6.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 China National Biotech Group Measles Vaccine Product Portfolio
6.7.5 China National Biotech Group Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Company Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bavarian Nordic Measles Vaccine Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Emergent Biosolutions
6.9.1 Emergent Biosolutions Company Information
6.9.2 Emergent Biosolutions Description and Business Overview
6.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Emergent Biosolutions Measles Vaccine Product Portfolio
6.9.5 Emergent Biosolutions Recent Developments/Updates
6.10 Medimmune
6.10.1 Medimmune Company Information
6.10.2 Medimmune Description and Business Overview
6.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Medimmune Measles Vaccine Product Portfolio
6.10.5 Medimmune Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Company Information
6.11.2 Johnson & Johnson Description and Business Overview
6.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Johnson & Johnson Measles Vaccine Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 CSL Limited
6.12.1 CSL Limited Company Information
6.12.2 CSL Limited Description and Business Overview
6.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CSL Limited Measles Vaccine Product Portfolio
6.12.5 CSL Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles Vaccine Industry Chain Analysis
7.2 Measles Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles Vaccine Production Mode & Process Analysis
7.4 Measles Vaccine Sales and Marketing
7.4.1 Measles Vaccine Sales Channels
7.4.2 Measles Vaccine Distributors
7.5 Measles Vaccine Customer Analysis
8 Measles Vaccine Market Dynamics
8.1 Measles Vaccine Industry Trends
8.2 Measles Vaccine Market Drivers
8.3 Measles Vaccine Market Challenges
8.4 Measles Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Sanofi Pasteur
Merck
Novartis
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
MedImmune
Johnson & Johnson
CSL Limited
Serum Institute of India
Pfizer Inc
Johnson & Johnson
List of Tables
 Table 1. Global Measles Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Measles Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Measles Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Measles Vaccine Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Measles Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Measles Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Measles Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Measles Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Measles Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Measles Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Measles Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Measles Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Measles Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Measles Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Measles Vaccine Sales by Region (2020-2025) & (K MT)
 Table 18. Global Measles Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Measles Vaccine Sales by Region (2026-2031) & (K MT)
 Table 20. Global Measles Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Measles Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Measles Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Measles Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Measles Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Measles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Measles Vaccine Sales by Country (2020-2025) & (K MT)
 Table 27. North America Measles Vaccine Sales by Country (2026-2031) & (K MT)
 Table 28. North America Measles Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Measles Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Measles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Measles Vaccine Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Measles Vaccine Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Measles Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Measles Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Measles Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Measles Vaccine Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Measles Vaccine Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Measles Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Measles Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Measles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Measles Vaccine Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Measles Vaccine Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Measles Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Measles Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Measles Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Measles Vaccine Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Measles Vaccine Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Measles Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Measles Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Measles Vaccine Sales (K MT) by Type (2020-2025)
 Table 51. Global Measles Vaccine Sales (K MT) by Type (2026-2031)
 Table 52. Global Measles Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Measles Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Measles Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Measles Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Measles Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Measles Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Measles Vaccine Price (USD/MT) by Type (2020-2025)
 Table 59. Global Measles Vaccine Price (USD/MT) by Type (2026-2031)
 Table 60. Global Measles Vaccine Sales (K MT) by Application (2020-2025)
 Table 61. Global Measles Vaccine Sales (K MT) by Application (2026-2031)
 Table 62. Global Measles Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Measles Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Measles Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Measles Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Measles Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Measles Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Measles Vaccine Price (USD/MT) by Application (2020-2025)
 Table 69. Global Measles Vaccine Price (USD/MT) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. GSK Measles Vaccine Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Sanofi-Pasteur Company Information
 Table 76. Sanofi-Pasteur Description and Business Overview
 Table 77. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Sanofi-Pasteur Measles Vaccine Product
 Table 79. Sanofi-Pasteur Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Merck Measles Vaccine Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Novartis Measles Vaccine Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Pfizer Measles Vaccine Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Serum Institute of India Company Information
 Table 96. Serum Institute of India Description and Business Overview
 Table 97. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Serum Institute of India Measles Vaccine Product
 Table 99. Serum Institute of India Recent Developments/Updates
 Table 100. China National Biotech Group Company Information
 Table 101. China National Biotech Group Description and Business Overview
 Table 102. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. China National Biotech Group Measles Vaccine Product
 Table 104. China National Biotech Group Recent Developments/Updates
 Table 105. Bavarian Nordic Company Information
 Table 106. Bavarian Nordic Description and Business Overview
 Table 107. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Bavarian Nordic Measles Vaccine Product
 Table 109. Bavarian Nordic Recent Developments/Updates
 Table 110. Emergent Biosolutions Company Information
 Table 111. Emergent Biosolutions Description and Business Overview
 Table 112. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Emergent Biosolutions Measles Vaccine Product
 Table 114. Emergent Biosolutions Recent Developments/Updates
 Table 115. Medimmune Company Information
 Table 116. Medimmune Description and Business Overview
 Table 117. Medimmune Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Medimmune Measles Vaccine Product
 Table 119. Medimmune Recent Developments/Updates
 Table 120. Johnson & Johnson Company Information
 Table 121. Johnson & Johnson Description and Business Overview
 Table 122. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Johnson & Johnson Measles Vaccine Product
 Table 124. Johnson & Johnson Recent Developments/Updates
 Table 125. CSL Limited Company Information
 Table 126. CSL Limited Description and Business Overview
 Table 127. CSL Limited Measles Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. CSL Limited Measles Vaccine Product
 Table 129. CSL Limited Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Measles Vaccine Distributors List
 Table 133. Measles Vaccine Customers List
 Table 134. Measles Vaccine Market Trends
 Table 135. Measles Vaccine Market Drivers
 Table 136. Measles Vaccine Market Challenges
 Table 137. Measles Vaccine Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Measles Vaccine
 Figure 2. Global Measles Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Measles Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture
 Figure 5. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture
 Figure 6. Global Measles Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Measles Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Children
 Figure 9. Adults
 Figure 10. Global Measles Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Measles Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Measles Vaccine Sales (2020-2031) & (K MT)
 Figure 13. Global Measles Vaccine Average Price (USD/MT) & (2020-2031)
 Figure 14. Measles Vaccine Report Years Considered
 Figure 15. Measles Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Measles Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Measles Vaccine Players: Market Share by Revenue in Measles Vaccine in 2024
 Figure 18. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Measles Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Measles Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Measles Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Measles Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Measles Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Measles Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Measles Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Measles Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Measles Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Measles Vaccine Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Measles Vaccine Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Measles Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Measles Vaccine by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Measles Vaccine by Type (2020-2031)
 Figure 55. Global Measles Vaccine Price (USD/MT) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Measles Vaccine by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Measles Vaccine by Application (2020-2031)
 Figure 58. Global Measles Vaccine Price (USD/MT) by Application (2020-2031)
 Figure 59. Measles Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Measles and Rubella Vaccines Market Research Report 2025
Global Measles and Rubella MR Vaccine Market Research Report 2025
Global Live Attenuated Measles Vaccine Market Research Report 2025
Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Paediatric Vaccine Market
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vaccines Market Research Report 2025
Vaccine Ampoules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Combinations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genetically Engineered Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aluminum based Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Shingles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions